State Health Investment Project: Impact Evaluation Endline Survey, 2017
Nigeria, 2017
Get Microdata
Reference ID
NGA_2017_HRBFIE-EL_v01_M
Producer(s)
Eeshani Kandpal (World Bank)
Created on
Dec 05, 2022
Last modified
Aug 28, 2024
Page views
101313
Downloads
314
- Data files
- cardio_drugs_noid.dta
- Catchment_Area_noid.dta
- decr_services_noid.dta
- diagnostic_kits_noid.dta
- FP_drugs_noid.dta
- general_drugs_noid.dta
-
Health Facility
(HF1)_noid.dta - HF1_Sect08_noid.dta
- HF1_sect10A_noid.dta
- HF1_Sect10B_noid.dta
- incr_services_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- malaria_drugs_noid.dta
- obstetric_care_noid.dta
- Q1611_positions_noid.dta
- services_noid.dta
- TB_drugs_noid.dta
- vaccines_noid.dta
- anc_patients_noid.dta
- HF3_HCP_Info_noid.dta
- HF4_HCP_Info_noid.dta
- HF4_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient DIRECT
OBSERVATION
(HF3_HF4)_noid.dta - HF5_ASSETS_noid.dta
- HF5_LIVESTOCK_noid.dta
- HF5_patients_noid.dta
- HF6_ASSETS_noid.dta
- HF6_LIVESTOCK_noid.dta
- HF6_patients_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
Patient EXIT
INTERVIEW
(HF5_HF6)_noid.dta -
Health Care
Provider
Interviews
(HF7)_noid.dta - HF7_Q202_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
- staff_roster_noid.dta
- Durable_Goods_noid.dta
- hhroster_noid.dta
- interview_actions_noid.dta
- interview_comments_noid.dta
-
NSHIP IE
Midline
Household Women
Questionnaire_noid.dta - Q16_13_noid.dta
- S5C_Assets_noid.dta
- S9_Vaccines_noid.dta
- Sec_05B_noid.dta
- Sec_06A_noid.dta
- Sec_06B_noid.dta
- Sec_06C_noid.dta
- Sec_07_noid.dta
Q11.21a) How much do you charge to patients for one dose of [DRUGS] in Naira? (Q1121b)
Data file: FP_drugs_noid.dta
Overview
Valid:
3155
Invalid:
-
Minimum:
0
Maximum:
2500
Type:
Discrete
Decimal:
0
Start:
3
End:
6
Width:
4
Range:
0 - 2500
Format:
Numeric
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 0 | 2936 |
93.1%
|
|
| 2 | 1 |
0%
|
|
| 3 | 3 |
0.1%
|
|
| 5 | 1 |
0%
|
|
| 6 | 1 |
0%
|
|
| 8 | 4 |
0.1%
|
|
| 9 | 1 |
0%
|
|
| 10 | 4 |
0.1%
|
|
| 15 | 1 |
0%
|
|
| 16 | 1 |
0%
|
|
| 20 | 2 |
0.1%
|
|
| 25 | 1 |
0%
|
|
| 30 | 1 |
0%
|
|
| 33 | 1 |
0%
|
|
| 40 | 3 |
0.1%
|
|
| 48 | 1 |
0%
|
|
| 50 | 20 |
0.6%
|
|
| 53 | 1 |
0%
|
|
| 60 | 3 |
0.1%
|
|
| 80 | 1 |
0%
|
|
| 100 | 33 |
1%
|
|
| 120 | 5 |
0.2%
|
|
| 144 | 1 |
0%
|
|
| 150 | 14 |
0.4%
|
|
| 160 | 1 |
0%
|
|
| 170 | 1 |
0%
|
|
| 200 | 25 |
0.8%
|
|
| 250 | 8 |
0.3%
|
|
| 300 | 13 |
0.4%
|
|
| 350 | 2 |
0.1%
|
|
| 400 | 5 |
0.2%
|
|
| 500 | 39 |
1.2%
|
|
| 600 | 2 |
0.1%
|
|
| 800 | 1 |
0%
|
|
| 1000 | 6 |
0.2%
|
|
| 1200 | 2 |
0.1%
|
|
| 1500 | 9 |
0.3%
|
|
| 2500 | 1 |
0%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.